1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics 2020 - France

Mental Health Analysis & Statistics 2020 - France

1-30 of about 100 reports

Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030

  • $ 3750
  • Aug 2020
  • 80 pages

‘Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Diabetic Peripheral Neuropathy ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • United States

Angelman Syndrome Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Angelman Syndrome - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Angelman Syndrome epidemiology in the 7MM, i.e., the United States, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • United States

Dementia with Diabetes - Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 90 pages

‘Dementia with Diabetes—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dementia with Diabetes epidemiology in the United States, ...

  • Dementia
  • Mental Health
  • France
  • Japan
  • Forecast

Dravet Syndrome Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Dravet Syndrome – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dravet Syndrome epidemiology in the 7MM, i.e., the United States, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • United States

Lennox Gastaut Syndrome - Epidemiology Forecast–2030

  • $ 3750
  • July 2020
  • 100 pages

‘Lennox Gastaut Syndrome (LGS) - Epidemiology Forecast - 2030’ report delivers an in-depth understanding of the Lennox Gastaut Syndrome (LGS), historical and forecasted epidemiology in the United States, ...

  • Mental Health
  • Neurological Disorder
  • France
  • Germany
  • United States

Treatment-resistant depression (TRD) - Epidemiology Forecast - 2030

  • $ 3750
  • June 2020
  • 100 pages

‘Treatment-resistant depression (TRD)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Treatment-resistant depression, historical and forecasted epidemiology in the ...

  • Depression
  • Mental Health
  • Pathology
  • Therapy
  • France

Pompe Disease - Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Pompe Disease (PD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pompe Disease in the United States, EU5 (Germany, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • United Kingdom

Frontotemporal Dementia (FTD)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Frontotemporal Dementia in the United ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • United States

Postpartum Depression - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Postpartum Depression (PPD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Postpartum Depression (PPD) epidemiology in the United ...

  • Depression
  • Mental Health
  • France
  • Germany
  • Forecast

Duchenne Muscular Dystrophy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Duchenne Muscular Dystrophy (DMD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Duchenne Muscular Dystrophy (DMD) epidemiology ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • United States

Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 83 pages

Overview ‘Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Adrenoleukodystrophy epidemiology in the 7MM, ...

  • Mental Health
  • Neurological Disorder
  • France
  • Japan
  • United States

France Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others.

  • $ 5995
  • January 2020
  • 224 pages

France Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. Summary new report, France Neurology Devices Market Outlook ...

  • Hospital
  • Medical Device
  • Mental Health
  • France
  • Sanofi S.A.

Multiple Sclerosis: Epidemiology Forecast to 2028

  • $ 3995
  • November 2019
  • 38 pages

Multiple Sclerosis: Epidemiology Forecast to 2028 Summary Multiple sclerosis (MS) is an autoimmune disease affecting principally the central nervous system that causes nerve sheath demyelination followed ...

  • Health Services
  • Mental Health
  • France
  • Italy
  • Forecast

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Cancer
  • Mental Health
  • Pathology
  • France
  • Demand

Genethon SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 35 pages

Summary Genethon SA (Genethon) is a non-profit biotherapy research and development organization which designs and develops gene therapy products for rare diseases.The company is developing gene therapy ...

  • Medical Biotechnology
  • Mental Health
  • Therapy
  • France
  • GenSight Biologics S.A.

Desitin Arzneimittel GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 17 pages

Summary Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) ...

  • Mental Health
  • Pharmaceutical
  • France
  • Deals & Alliance
  • Desitin Arzneimittel GmbH

France Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • November 2018
  • 198 pages

France Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others Summary GlobalData’s new report, France Neurology Devices ...

  • Hospital
  • Mental Health
  • Neuromodulation Device
  • France
  • Sanofi S.A.

Pharnext SA (ALPHA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 35 pages

Summary Pharnext SA (Pharnext), formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases.The company offers pleotherapy, a proprietary research ...

  • Healthcare
  • Mental Health
  • Pharmaceutical
  • France
  • Pharnext

EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • April 2018
  • 86 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Epilepsy in 19 Major Markets Epilepsy is a complex neurologic disorder characterised by the occurrence of seizures, divided into several types ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • Italy

EpiCast Report: Epilepsy - Epidemiology Forecast to 2026

  • $ 3995
  • October 2017
  • 45 pages

EpiCast Report: Epilepsy - Epidemiology Forecast to 2026 Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • Forecast

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

  • $ 3995
  • October 2017
  • 37 pages

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026 Summary Alzheimer’s disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, ...

  • Dementia
  • Mental Health
  • France
  • Spain
  • Forecast

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Depression
  • Mental Health
  • Pathology
  • France
  • Forecast

Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • France
  • Forecast

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Europe
  • France

Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Panic Disorder patients study in a new report ‘Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Panic ...

  • Anxiety Disorder
  • Mental Health
  • Pathology
  • France
  • Forecast

Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Obsessive Compulsive Disorder patients study in a new report ‘Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Mental Health
  • Pathology
  • Personality Disorder
  • Europe
  • France

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • France
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Major Depression patients study in a new report ‘Europe Major Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Depression
  • Mental Health
  • Pathology
  • France
  • Forecast

Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Huntington’s Disease patients study in a new report ‘Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Dementia
  • Mental Health
  • Pathology
  • Europe
  • France

Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Gaucher's Disease patients study in a new report ‘Europe Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Europe
  • France

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on